Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Catechols »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Catecholamines < Catechols < Cathartics  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
000745 (2002) Ashfaq A. Sharif [États-Unis]Entacapone in restless legs syndrome.
000866 (2002) COMT inhibitors: management of Parkinson's disease.
000956 (2002) Alexander Fisher [Australie] ; James Croft-Baker ; Michael Davis ; Patrick Purcell ; Allan J. McleanEntacapone-induced hepatotoxicity and hepatic dysfunction.
000A52 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter JennerEffect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
000F26 (2004) Jan C M. Zijlmans [Royaume-Uni] ; Berengere Debilly ; Olivier Rascol ; Andrew J. Lees ; Franck DurifSafety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study.
001021 (2005) Paolo Lamberti [Italie] ; Stefano Zoccolella ; Giovanni Iliceto ; Elio Armenise ; Angela Fraddosio ; Michele De Mari ; Paolo LivreaEffects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.
001074 (2005) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Ghassan Al-Barghouthy ; Sarah Rose ; Mikko Kuoppamaki ; Warren Olanow ; Peter JennerMultiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.
001221 (2005) Katherine L. Widnell [États-Unis] ; Cynthia ComellaRole of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations.
001471 (2006) Thomas Müller [Allemagne] ; Christoph Erdmann ; Siegfried Muhlack ; Dirk Bremen ; Horst Przuntek ; Dirk WoitallaInhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels.
001549 (2006) Concepci Marin [Espagne] ; Esther Aguilar ; José A. ObesoCoadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats.
001897 (2006) Alexei Korchounov [Allemagne] ; Gregory BogomazovEmployment, medical absenteeism, and disability perception in Parkinson's disease: A pilot double-blind, randomized, placebo-controlled study of entacapone adjunctive therapy.
001946 (2007) Entacapone to tolcapone switch: Multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease.
001953 (2007) Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa ; Sadako Kuno ; Nobuo Yanagisawa ; Mitsutoshi Yamamoto ; Tomoyoshi KondoPlacebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients.
001C09 (2007) Jonas LindhShort episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine.
001C35 (2007) Günther Deuschl [Allemagne] ; Antanas Vaitkus ; Gabriele-Cornelia Fox ; Torsten Roscher ; Dieter Schremmer ; Ariel GordinEfficacy and tolerability of Entacapone versus Cabergoline in parkinsonian patients suffering from wearing-off.
002177 (2008) Thomas Müller [Allemagne] ; Dirk Woitalla ; Oliver Goetze ; Christoph ErdmannEntacapone improves absorption of a coadministered salt in patients with Parkinson's disease.
002370 (2009) Victor S C. Fung [Australie] ; Lilie Herawati ; Ying WanQuality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
002450 (2009) Robert A. Hauser [États-Unis] ; Michel Panisset ; Giovanni Abbruzzese ; Linda Mancione ; Nalina Dronamraju ; Algirdas KakariekaDouble-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
002486 (2009) Nir Giladi [Israël] ; Joseph Tal ; Tali Azulay ; Oliver Rascol ; David J. Brooks ; Eldad Melamed ; Wolfgang Oertel ; Werner Poewe [Autriche] ; Fabrizio Stocchi ; Eduardo TolosaValidation of the freezing of gait questionnaire in patients with Parkinson's disease.
002643 (2009) Peter A. Lewitt [États-Unis] ; Danna Jennings ; Kelly E. Lyons ; Rajesh Pahwa ; Adrian L. Rabinowicz ; James Wang ; Maria Guarnieri ; Jean P. Hubble ; Harold MurckPharmacokinetic-pharmacodynamic crossover comparison of two levodopa extension strategies.
002837 (2009) Davide Manca ; Giovanni Cossu ; Daniela Murgia ; Andrea Molari ; Paola Ferrigno ; Emanuele Marcia ; Maurizio MelisReversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Catechols" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Catechols" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Catechols
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024